Yes, there are biomarkers that indicate the migratory potential of tumor cells. Proteins involved in EMT, such as vimentin and N-cadherin, are commonly used as indicators. Additionally, elevated levels of MMPs in the blood or tissue samples can serve as biomarkers for metastatic potential. Detection of circulating tumor cells (CTCs) in the bloodstream is another method to assess migration.